Atlas Trials

A Bioequivalence Study of Docetaxel Injection in Patients With Solid Tumours

Clinical trial NCT04889599 · COMPLETED

Trial details

NCT number
NCT04889599
Sponsor
Zhuhai Beihai Biotech Co., Ltd
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
DocetaxelSolid TumoursBioequivalence
Start date
2021-04-29
Primary completion
2021-09-17
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.